<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Pouly S</dc:creator>
  <dc:creator>Matthieu JM</dc:creator>
  <dc:creator>Honegger P</dc:creator>
  <dc:date>2001</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">In previous work we found that mezerein, a C kinase activator, as well as basic fibroblast growth factor (FGF-2) induce demyelination and partial oligodendrocyte dedifferentiation in highly differentiated aggregating brain cell cultures. Here we show that following protein kinase C activator-induced demyelination, effective remyelination occurs. We found that mezerein or FGF-2 caused a transient increase in DNA synthesis following a pronounced decrease of the myelin markers myelin basic protein and 2',3'-cyclic nucleotide 3'-phosphohydrolase. Both oligodendrocytes and astrocytes were involved in this mitogenic response. Within 17 days after demyelination, myelin was restored to the level of the untreated controls. Transient mitotic activity was indispensable for remyelination. The present results suggest that myelinating oligodendrocytes retain the capacity to reenter the cell cycle, and that this plasticity is important for the regeneration of the oligodendrocyte lineage and remyelination. Although it cannot be excluded that a quiescent population of oligodendrocyte precursor cells was present in the aggregates and able to proliferate, differentiate and remyelinate, we could not find evidence supporting this view.</dc:description>
  <dc:identifier>https://sonar.ch/global/documents/139192</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1023/a:1010931102287</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/pmid/11519722</dc:relation>
  <dc:source>Neurochemical research. - 2001</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">2',3'-Cyclic-Nucleotide Phosphodiesterases</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">Animals</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">Becaplermin</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">Biomarkers</dc:subject>
  <dc:subject xmlns:ns5="xml" ns5:lang="en">Brain</dc:subject>
  <dc:subject xmlns:ns6="xml" ns6:lang="en">Cell Division</dc:subject>
  <dc:subject xmlns:ns7="xml" ns7:lang="en">Cytarabine</dc:subject>
  <dc:subject xmlns:ns8="xml" ns8:lang="en">DNA</dc:subject>
  <dc:subject xmlns:ns9="xml" ns9:lang="en">Demyelinating Diseases</dc:subject>
  <dc:subject xmlns:ns10="xml" ns10:lang="en">Diterpenes</dc:subject>
  <dc:subject xmlns:ns11="xml" ns11:lang="en">Enzyme Activation</dc:subject>
  <dc:subject xmlns:ns12="xml" ns12:lang="en">Fetus</dc:subject>
  <dc:subject xmlns:ns13="xml" ns13:lang="en">Fibroblast Growth Factor 2</dc:subject>
  <dc:subject xmlns:ns14="xml" ns14:lang="en">In Vitro Techniques</dc:subject>
  <dc:subject xmlns:ns15="xml" ns15:lang="en">Mitosis</dc:subject>
  <dc:subject xmlns:ns16="xml" ns16:lang="en">Myelin Basic Protein</dc:subject>
  <dc:subject xmlns:ns17="xml" ns17:lang="en">Myelin Sheath</dc:subject>
  <dc:subject xmlns:ns18="xml" ns18:lang="en">Oligodendroglia</dc:subject>
  <dc:subject xmlns:ns19="xml" ns19:lang="en">Platelet-Derived Growth Factor</dc:subject>
  <dc:subject xmlns:ns20="xml" ns20:lang="en">Protein Kinase C</dc:subject>
  <dc:subject xmlns:ns21="xml" ns21:lang="en">Proto-Oncogene Proteins c-sis</dc:subject>
  <dc:subject xmlns:ns22="xml" ns22:lang="en">Rats</dc:subject>
  <dc:subject xmlns:ns23="xml" ns23:lang="en">Terpenes</dc:subject>
  <dc:title xmlns:ns24="xml" ns24:lang="en">Remyelination in vitro following protein kinase C activator-induced demyelination.</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
